Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-MVA Triplex Vaccine in Pediatric Patients Receiving an Allogeneic Hematopoietic Stem Cell Transplant
NCT03354728Phase 2Recruiting
- Sponsor
- City of Hope
- Start
- Aug 2018
- Primary completion
- Dec 2026
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Triplex in cytomegalovirus infection (CMV), sponsored by City of Hope. Started Aug 2018; status: recruiting.
02
Drugs
Triplex
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT03354728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03354728.